Citation Impact
Citing Papers
Computational Radiomics System to Decode the Radiographic Phenotype
2017 Standout
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Influence of Prophylactic Neck Dissection on Rate of Retreatment for Papillary Thyroid Carcinoma
2013
Recombinant human thyrotropin-aided versus thyroid hormone withdrawal-aided radioiodine treatment for differentiated thyroid cancer after total thyroidectomy: A meta-analysis
2014
Effects of Low-Dose and High-Dose Postoperative Radioiodine Therapy on the Clinical Outcome in Patients with Small Differentiated Thyroid Cancer Having Microscopic Extrathyroidal Extension
2013
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Italian consensus for the classification and reporting of thyroid cytology
2014 Standout
Thyroid cancer
2016 Standout
Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period
2008 Standout
Post-operative neck ultrasound and risk stratification in differentiated thyroid cancer patients with initial lymph node involvement
2014
Applications and limitations of radiomics
2016
Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients
2013
Head and neck cancer
2008 Standout
Long-Term Survival in Differentiated Thyroid Cancer Is Worse After Low-Activity Initial Post-Surgical131I Therapy in Both High- and Low-Risk Patients
2014
Recombinant Human Thyroid-Stimulating Hormone To Stimulate 131-1 Uptake For Remnant Ablation And Adjuvant Therapy
2012
The Bethesda System for Reporting Thyroid Cytopathology: A Meta-Analysis
2012 Standout
Revisiting the Guidelines Issued by the Japanese Society of Thyroid Surgeons and Japan Association of Endocrine Surgeons: A Gradual Move Towards Consensus Between Japanese and Western Practice in the Management of Thyroid Carcinoma
2014
European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS
2017 Standout
Progress in molecular-based management of differentiated thyroid cancer
2013
ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee
2017 Standout
Effectiveness of retinoic acid treatment for redifferentiation of thyroid cancer in relation to recovery of radioiodine uptake
2009
Low-Risk Differentiated Thyroid Cancer and Radioiodine Remnant Ablation: A Systematic Review of the Literature
2015
Ultrasensitive serum thyroglobulin measurement is useful for the follow-up of patients treated with total thyroidectomy without radioactive iodine ablation
2013
The Economic Cost of Thyroid Cancer in France and the Corresponding Share Associated With Treatment of Overdiagnosed Cases
2023
rhTSH-aided low-activity versus high-activity regimens of radioiodine in residual ablation for differentiated thyroid cancer
2013
Update on Differentiated Thyroid Cancer Staging
2014
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
Current management of pediatric thyroid disease and differentiated thyroid cancer
2015
High versus low radioiodine activity in patients with differentiated thyroid cancer: A meta-analysis
2012
Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum
2011 Standout
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
The 2017 Bethesda System for Reporting Thyroid Cytopathology
2017 Standout
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
High-Risk Patients with Differentiated Thyroid Cancer T4 Primary Tumors Achieve Remnant Ablation Equally Well Using rhTSH or Thyroid Hormone Withdrawal
2013
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
2017 Standout
Oxidative Stress, Prooxidants, and Antioxidants: The Interplay
2014 Standout
The Effectiveness of Recombinant Human Thyroid-Stimulating Hormone versus Thyroid Hormone Withdrawal Prior to Radioiodine Remnant Ablation in Thyroid Cancer: A Meta-Analysis of Randomized Controlled Trials
2014
Radioiodine therapy for patients with differentiated thyroid cancer after thyroidectomy: direct comparison and network meta-analyses.
2013
Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinoma
2013
Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors
2013 Standout
Patients With Differentiated Thyroid Cancer Who Underwent Radioiodine Thyroid Remnant Ablation With Low-Activity 131I After Either Recombinant Human TSH or Thyroid Hormone Therapy Withdrawal Showed the Same Outcome After a 10-Year Follow-up
2013
Low- or High-Dose Radioiodine Remnant Ablation for Differentiated Thyroid Carcinoma: A Meta-Analysis
2013
Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer
2012
Radioiodine Therapy in Benign Thyroid Diseases: Effects, Side Effects, and Factors Affecting Therapeutic Outcome
2012
PET-based treatment planning in radiotherapy: a new standard?
2007
Cancer treatment and survivorship statistics, 2019
2019 Standout
American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix
2016 Standout
Guidelines for the management of thyroid cancer
2014 Standout
A Novel Mass Spectrometry–Based Assay for the Accurate Measurement of Thyroglobulin from Patient Samples Containing Antithyroglobulin Autoantibodies
2012
No Adverse Affect in Clinical Outcome Using Low Preablation Diagnostic 131I Activity in Differentiated Thyroid Cancer: Refuting Thyroid-Stunning Effect
2014
Thyroid nodules and differentiated thyroid cancer: update on the Brazilian consensus
2013
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of Slimane Zerdoud being referenced
Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer
2012
Intérêt de la tomographie par émission de positons au [18F]-fluoro-2-désoxyglucose dans la détermination des volumes cibles de radiothérapie. Application à l'irradiation conformationnelle des cancers bronchiques non à petites cellules
2005
Radioactive iodine therapy, molecular imaging and serum biomarkers for differentiated thyroid cancer: 2017 guidelines of the French Societies of Nuclear Medicine, Endocrinology, Pathology, Biology, Endocrine Surgery and Head and Neck Surgery
2017
The retrospective binning method improves the consistency of phase binning in respiratory-gated PET/CT
2012
Defective Efficacy of Retinoic Acid Treatment in Patients with Metastatic Thyroid Carcinoma
2006